bortezomib,ciltacabtagene autoleucel,lenalidomide,dexamethasone,Idecabtagene vicleucel
bms,janssen
['mmsm', 'determination', 'cilta-cel']
we spoke with nikhil munshi today at #eha2022 on the approval of ide-cel &amp; cilta-cel in myeloma, the determination trial, and more! follow us for more updates &amp; our expert interviews. #hemonc #mmsm #myeloma #immunoonc 
The Video Journal of Hematological Oncology provides trusted information to improve knowledge of hematological cancers. VJHemOnc is intended for HCPs only.